SCAMP3 showed higher expression in AML with a fold change of 2.988, in T-ALL with a fold change of 2.016 and in B-ALL with a fold change of 2.227 compared to normal controls in Andersson’s dataset; and SCAMP5 showed overexpression in AML with a fold change of 1.725. This evidence concerns the gene SCAMP5 and acute lymphoblastic leukemia.